4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-20-025166
Options or other derivatives
- Director acquired 5,907.15 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Katkin Keith Director | 2020-09-11 | Grant or award · Stock Option (Right to Buy) | +5,907.15 | 5,907.15 | D | ||
Loading xslF345X03/doc4.xml…